# Regulations.gov document: Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01% — retained record

> Retained regulations record from regulations-gov.

Canonical: https://highsignal.app/data/records/c0fa3c6d6414c961

[← sources](https://highsignal.app/data)

Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%

source: [regulations](https://highsignal.app/data/regulations) (regulations-gov)  published 2026-09-25 04:00 ingested 2026-09-26 02:39

[original source ↗](https://www.regulations.gov/document/FDA-2026-N-10606-0001)

## retained text



```
Query: data center
Agency: FDA
Type: Notice
Docket: FDA-2026-N-10606
Comment end: 2026-10-30T03:59:59Z
```



document fetched 2026-09-28 02:43 · canonical https://regulations.gov/document/FDA-2026-N-10606-0001